Total Payments
$13,887
2024 Payments
$336.01
Companies
29
Transactions
308
Medicare Patients
6,613
Medicare Billing
$999,331
Payment Breakdown by Category
Food & Beverage$8,057 (58.0%)
Travel$5,599 (40.3%)
Education$232.13 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,057 | 297 | 58.0% |
| Travel and Lodging | $5,599 | 6 | 40.3% |
| Education | $232.13 | 5 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $6,236 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,967 | 167 | $0 (2023) |
| Abbott Laboratories | $963.90 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $947.14 | 25 | $0 (2024) |
| BIOTRONIK INC. | $477.01 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $474.71 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $371.91 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $332.46 | 13 | $0 (2024) |
| ABIOMED | $270.21 | 8 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $264.26 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.01 | 11 | E.R. Squibb & Sons, L.L.C. ($118.25) |
| 2023 | $981.34 | 21 | Merck Sharp & Dohme LLC ($235.77) |
| 2022 | $1,053 | 30 | Novartis Pharmaceuticals Corporation ($275.23) |
| 2021 | $1,544 | 47 | Novartis Pharmaceuticals Corporation ($421.96) |
| 2020 | $290.50 | 23 | Novartis Pharmaceuticals Corporation ($233.59) |
| 2019 | $7,021 | 72 | Medtronic Vascular, Inc. ($5,851) |
| 2018 | $1,143 | 54 | Novartis Pharmaceuticals Corporation ($298.30) |
| 2017 | $1,519 | 50 | BIOTRONIK INC. ($314.00) |
All Payment Transactions
308 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $118.25 | General |
| Category: Cardiovascular | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Transcatheter Heart Valves | ||||||
| 01/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.86 | General |
| Category: Cardiovascular | ||||||
| 10/30/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $61.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/18/2023 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $83.35 | General |
| Category: Transcatheter Heart Valves | ||||||
| 08/10/2023 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Transcatheter Heart Valves | ||||||
| 07/26/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $124.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/20/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/01/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $116.84 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,355 | 2,773 | $955,014 | $237,184 |
| 2022 | 19 | 1,629 | 3,410 | $1.1M | $256,860 |
| 2021 | 20 | 1,592 | 3,302 | $956,773 | $246,033 |
| 2020 | 19 | 2,037 | 4,063 | $1.1M | $259,255 |
Total Patients
6,613
Total Services
13,548
Medicare Billing
$999,331
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 970 | $242,400 | $98,175 | 40.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 116 | 446 | $83,848 | $29,565 | 35.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 30 | 150 | $102,000 | $26,516 | 26.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 112 | $59,136 | $16,274 | 27.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 80 | 84 | $113,400 | $14,655 | 12.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 24 | 25 | $30,000 | $9,932 | 33.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 21 | 44 | $17,600 | $8,236 | 46.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 111 | 116 | $156,600 | $6,654 | 4.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $20,400 | $5,503 | 27.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 24 | 100 | $15,000 | $4,836 | 32.2% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $22,500 | $3,593 | 16.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $9,600 | $3,449 | 35.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 34 | $5,950 | $2,438 | 41.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 263 | 343 | $46,305 | $2,332 | 5.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 28 | 30 | $12,000 | $1,613 | 13.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $3,525 | $1,571 | 44.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 72 | 77 | $10,780 | $943.66 | 8.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 54 | 67 | $3,350 | $637.84 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 31 | $620.00 | $260.40 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 852 | $212,775 | $87,230 | 41.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 134 | 720 | $135,360 | $44,049 | 32.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 144 | $97,920 | $26,706 | 27.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 117 | 138 | $72,864 | $23,398 | 32.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 82 | 85 | $114,750 | $15,176 | 13.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 28 | 28 | $33,600 | $12,091 | 36.0% |
About Dr. Narayanaiyengar Devaraj, MD
Dr. Narayanaiyengar Devaraj, MD is a Cardiovascular Disease healthcare provider based in Anaheim, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639133960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Narayanaiyengar Devaraj, MD has received a total of $13,887 in payments from pharmaceutical and medical device companies, with $336.01 received in 2024. These payments were reported across 308 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($8,057).
As a Medicare-enrolled provider, Devaraj has provided services to 6,613 Medicare beneficiaries, totaling 13,548 services with total Medicare billing of $999,331. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Anaheim, CA
- Active Since 04/13/2006
- Last Updated 10/08/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1639133960
Products in Payments
- Resolute (Device) $5,851
- ENTRESTO (Drug) $1,639
- FARXIGA (Drug) $654.42
- VERQUVO (Drug) $474.71
- Kerendia (Drug) $371.91
- ELIQUIS (Drug) $317.66
- Micra (Device) $280.93
- BRILINTA (Drug) $278.26
- LifeVest (Device) $264.26
- Impella (Device) $261.15
- JARDIANCE (Drug) $245.92
- LEQVIO (Drug) $213.96
- Repatha (Biological) $213.01
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $197.22
- HeartMate (Device) $189.55
- MitraClip System (Device) $162.44
- PRESSUREWIRE (Device) $137.95
- Xience Sierra Coronary Stent System (Device) $130.88
- Reveal LINQ (Device) $127.05
- SAMSCA (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Anaheim
Raveen Arora, M.d, M.D
Cardiovascular Disease — Payments: $151,294
Cardiovascular Disease $151,294
David Suk, Md, MD
Cardiovascular Disease — Payments: $10,578
Cardiovascular Disease $10,578
Ameesh Parikh, M.d, M.D
Cardiovascular Disease — Payments: $5,378
Cardiovascular Disease $5,378
David Kramer, M.d, M.D
Cardiovascular Disease — Payments: $3,482
Cardiovascular Disease $3,482
Dr. Prasanna Challa, M.d, M.D
Cardiovascular Disease — Payments: $1,845
Cardiovascular Disease $1,845
Ravi Jandhyala, Md, MD
Cardiovascular Disease — Payments: $1,831
Cardiovascular Disease $1,831